OTTek

Company Overview

Snapshot

Founded in July 2018 by Yoav Lichtenstein, OTTek operates with 1-10 employees. The company has raised $406K across two funding rounds from two investors, with its last public funding round in March 2022.

Business overview

OTTek, also known as Over Tube Technology, is a Health Tech & Life Sciences company developing a proprietary solution for efficient colon cleansing during colonoscopy procedures. Its core product, the C-Clear, is a single-use device designed to reduce risks associated with poor visualization in an insufficiently prepared colon and to facilitate successful procedure completion. Compatible with most endoscopes, the C-Clear creates a parallel evacuation channel for rapid and efficient cleansing. OTTek operates in the medical devices, gastroenterology, hospitals, diagnostics, surgery, and endoscopy sectors, serving healthcare providers and the medical devices industry.

Company Intelligence Q&A

What is OTTek's primary product?

OTTek's primary product is the C-Clear, a single-use device designed to improve colon cleansing efficiency during colonoscopy procedures by creating a parallel evacuation channel to the endoscope.

When was OTTek founded and by whom?

OTTek was founded in July 2018 by Yoav Lichtenstein.

What is the status of OTTek?

OTTek is currently Non Active, having ceased to operate in March 2025.

Which incubator is OTTek a part of?

OTTek is a portfolio company of the NGT3 incubator.

What is OTTek's product stage?

OTTek's product, the C-Clear, is currently in the Clinical Trial stage. This stage involves testing the device in human subjects to evaluate its safety and efficacy before seeking regulatory approval.